NOT-CA-21-115: Notice of Pre-Application Webinar for the "Translational and Basic Science Research in Early Lesions (TBEL)" Program: RFA-CA-21-054 and RFA-CA-21-055

Notice of Pre-Application Webinar for the "Translational and Basic Science Research in Early Lesions (TBEL)" Program: RFA-CA-21-054 and RFA-CA-21-055

Notice Number:

NOT-CA-21-115

Key Dates

Release Date:

September 9, 2021

Related Announcements

RFA-CA-21-054 - Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)

RFA-CA-21-055 - Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application teleconference on September 24, 2021, at 1:00-3:00 pm (ET) for the Translational and Basic Science Research in Early Lesions (TBEL) Funding Opportunity Announcements (FOAs):

1) RFA-CA-21-054 - Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed); and

2) RFA-CA-21-055 - Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)

NCI staff members involved in managing the TBEL program will provide technical assistance to potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees.

Potential applicants are encouraged to submit their questions or comments to Dr. Elisa Woodhouse ([email protected]) or Dr. Christos Patriotis ([email protected]) in advance of the teleconference. Please include "NCI Technical Assistance Webinar for TBEL FOAs” in the subject line of the email.

Registration: Potential applicants interested in participating in the teleconference should use the provided registration link (Register Here) no later than 5:00 p.m. (ET), September 20, 2021. Upon completion of registration, a confirmation e-mail will be sent together with a calendar invitation that will also include a Webex link for joining the teleconference on September 24, 2021.

Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-21-054 or RFA-CA-21-055.

Inquiries

Please direct all inquiries to:

Elisa Woodhouse, Ph.D.
National Cancer Institute (NCI)

Telephone: 240-276-6220
Email: [email protected]

Christos Patriotis, Ph.D.
National Cancer Institute (NCI)

Telephone: 240-276-7134
Email: [email protected]